Village Green Apothecary Supplements

Our assessment

Based on FDA adverse event data, the overall safety profile for this supplement appears to be favorable, with a low volume of reported incidents. The data shows 1 product under the brand name, and no significant safety signals have been identified that would warrant widespread concern. However, as a pharmacovigilance specialist, I must emphasize that any adverse event report is taken seriously, and patient safety remains the top priority FDA FAERS ↗.

Safety profile

FDA received a total of 1 adverse event report for this product. The specific side effects reported include data that is not available in the provided dataset. Without detailed breakdowns of the reported events, I cannot list specific symptoms or their frequency beyond the single report count. This limitation underscores the need for continued monitoring and more comprehensive reporting to fully understand the risk profile FDA FAERS ↗.

How it works

Data on the mechanism of action is not available from the provided information. The drug interaction data is listed as N/A, meaning no specific interactions have been recorded in the provided dataset. Patients should always consult with a healthcare provider before starting any new supplement, especially if they are taking other medications, as the absence of reported interactions does not guarantee safety FDA FAERS ↗.

Our recommendation

Given the very limited data—only 1 product and 1 adverse event report—it is impossible to make a definitive safety assessment. I recommend that patients and healthcare providers remain vigilant. Anyone considering this supplement should watch for any new or unusual symptoms and report them to their doctor and the FDA’s MedWatch program. Without more robust data, the safest course is to prioritize well-documented alternatives and to use this product only under professional medical supervision FDA FAERS ↗.